Adipokine profile in glucocorticoid-treated patients: Baseline plasma leptin level predicts occurrence of lipodystrophy

Clinical Endocrinology

Volumn 78, Issue 1, 2013, Pages 43-51

  Fardet, Laurence ^a,b,c   Antuna Puente, Barbara ^c   Vatier, Camille ^c   Cervera, Pascale ^a,b,c   Touati, Amel ^a   Simon, Tabassome ^a,b   Capeau, Jacqueline ^a,c,d   Fève, Bruno ^a,c   Bastard, Jean Philippe ^c,d  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^d HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; LEPTIN; PREDNISONE; RESISTIN;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; FEMALE; GLUCOCORTICOID INDUCED LIPODYSTROPHY; HUMAN; LIPODYSTROPHY; MACROPHAGE; MALE; PHOTOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SYSTEMIC THERAPY;

ADIPOKINES; ADIPOSE TISSUE; ADULT; AGED; GLUCOCORTICOIDS; HUMANS; LEPTIN; LIPODYSTROPHY; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84870882005     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04348.x     Document Type: Article

References (39)

1. Fardet, L., Petersen, I., &, Nazareth, I., (2011) Prevalence of long-term oral glucocorticoids prescriptions in UK over the last 20 years. Rheumatology (Oxford), 50, 1982-1990.
2. Fardet, L., Cabane, J., Lebbé, C., et al. (2007) Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study. Journal of the American Academy of Dermatology, 57, 604-609.
3. Tataranni, P.A., Larson, D.E., Snitker, S., et al. (1996) Effects of glucocorticoids on energy metabolism and food intake in humans. American Journal of Physiology, 1996, E317-E325.
4. Gaillard, D., Wabitsch, M., Pipy, B., et al. (1991) Control of terminal differentiation of adipose precursor cells by glucocorticoids. Journal of Lipid Research, 32, 569-579.
5. Aubert, J., Darimont, C., Safonova, I., et al. (1997) Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochemical Journal, 328, 701-706.
6. Arena, C., Morin, A.S., Blanchon, T., et al. (2010) Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy. British Journal of Dermatology, 163, 832-837.
7. Fardet, L., Cabane, J., Kettaneh, A., et al. (2007) Corticosteroid- induced lipodystrophy is associated with features of the metabolic syndrome. Rheumatology (Oxford), 46, 1102-1106.
8. Vigouroux, C., Maachi, M., Nguyên, T.H., et al. (2003) Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS, 17, 1503-1511.
9. Misra, A., Peethambaram, A., &, Garg, A., (2004) Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore), 83, 18-34.
10. Feve, B., &, Bastard, J.P., (2009) The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nature Reviews. Endocrinology, 5, 305-311.
11. Rieth, N., Jollin, L., Le Panse, B., et al. (2009) Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men. European Journal of Applied Physiology, 105, 309-313.
12. Uddén, J., Björntorp, P., Arner, P., et al. (2003) Effects of glucocorticoids on leptin levels and eating behaviour in women. Journal of Internal Medicine, 253, 225-231.
13. Vigouroux, C., Caron-Debarle, M., Le Dour, C., et al. (2011) Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. International Journal of Biochemistry and Cell Biology, 43, 862-876.
14. Bergman, R.N., Stefanovski, D., Buchanan, T.A., et al. (2011) A better index of body adiposity. Obesity (Silver Spring), 19, 1083-1089.
15. Fardet, L., Kettaneh, A., Tiev, K.P., et al. (2008) Digital photography as an operational tool for assessing corticosteroid-induced lipodystrophy. European Journal of Internal Medicine, 19, 340-344.
16. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
17. Lihn, A.S., Richelsen, B., Pedersen, S.B., et al. (2003) Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. American Journal of Physiology. Endocrinology and Metabolism, 285, E1072-E1080.
18. Oge, A., Bayraktar, F., Saygili, F., et al. (2005) TSH influences serum leptin levels independent of thyroid hormones in hypothyroid and hyperthyroid patients. Endocrine Journal, 52, 213-217.
19. Merabet, E., Dagogo-Jack, S., Coyne, D.W., et al. (1997) Increased plasma leptin concentration in end-stage renal disease. Journal of Clinical Endocrinology and Metabolism, 82, 847-850.
20. Dagogo-Jack, S., Tykodi, G., &, Umamaheswaran, I., (2005) Inhibition of cortisol biosynthesis decreases circulating leptin levels in obese humans. Journal of Clinical Endocrinology and Metabolism, 90, 5333-5335.
21. Di Carlo, C., Tommaselli, G.A., &, Nappi, C., (2002) Effects of sex steroid hormones and menopause on serum leptin concentrations. Gynecological Endocrinology, 16, 479-491.
22. Horber, F.F., Zurcher, R.M., Herren, H., et al. (1986) Altered body fat distribution in patients with glucocorticoid treatment and in patients on long-term dialysis. American Journal of Clinical Nutrition, 43, 758-769.
23. Nordborg, E., Schaufelberger, C., &, Bosaeus, I., (1998) The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis. Scandinavian Journal of Rheumatology, 27, 106-111.
24. Covar, R.A., Leung, D.Y., McCormick, D., et al. (2000) Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. Journal of Allergy and Clinical Immunology, 106, 651-659.
25. Benet, L.Z., Frey, F.J., Amend Jr, W.J., et al. (1982) Endogenous and exogenous glucocorticoids in cushingoid patients. Drug Intelligence & Clinical Pharmacy, 16, 863-868.
26. Bergrem, H., Jervell, J., &, Flatmark, A., (1985) Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients. Kidney International, 27, 459-464.
27. Calmy, A., Carey, D., Mallon, P.W., et al. (2008) Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy. HIV Medicine, 9, 101-110.
28. Thaler, J.P., &, Schwartz, M.W., (2010) Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology, 151, 4109-4115.
29. Degawa-Yamauchi, M., Moss, K.A., Bovenkerk, J.E., et al. (2005) Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obesity Research, 13, 662-669.
30. Fiorenza, C.G., Chou, S.H., &, Mantzoros, C.S., (2011) Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol, 7, 137-150.
31. Shinahara, M., Nishiyama, M., Iwasaki, Y., et al. (2009) Plasma adiponectin levels are increased despite insulin resistance in corticotrophin-releasing hormone transgenic mice, an animal model of Cushing syndrome. Endocrine Journal, 56, 879-886.
32. Jang, C., Inder, W.J., Obeyesekere, V.R., et al. (2008) Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clinical Endocrinology (Oxford), 69, 745-750.
33. Kim, K.H., Zhao, L., Moon, Y., et al. (2004) Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America, 101, 6780-6785.
34. Escoté, X., Miranda, M., Veloso, S., et al. (2011) Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin. Journal of Acquired Immune Deficiency Syndromes, 57, 16-23.
35. Escher, G., Galli, I., Vishwanath, B.S., et al. (1997) Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. The Journal of Experimental Medicine, 186, 189-198.
36. Tomlinson, J.W., Moore, J., Cooper, M.S., et al. (2001) Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology, 142, 1982-1989.
37. Tan, C.Y., &, Vidal-Puig, A., (2008) Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochemical Society Transactions, 36, 935-940.
38. Tilg, H., &, Moschen, A.R., (2008) Inflammatory mechanisms in the regulation of insulin resistance. Molecular Medicine, 14, 222-231.
39. Kreiner, F., &, Galbo, H., (2010) Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica. Scandinavian Journal of Rheumatology, 39, 402-408.